MANHASSET, NY – Feinstein Institute for Medical Research Elmezzi Graduate School of Molecular Medicine Scholar Gavin H. Imperato, MD, has been named a Public Policy Fellow of the American Association of Immunologists (AAI) for 2018-2019.
Dr. Imperato is a PhD candidate at the Elmezzi Graduate School where he studies the neuroscience of immunity. He works with researchers in the emerging field of bioelectronic medicine, which combines neuroscience, molecular biology, and bioengineering to tap into the nervous system to treat disease and injury without the use of pharmaceuticals. Dr. Imperato looks to understand the neural signals which activate the immune system so they can be harnessed to treat various medical conditions. By being selected into AAI’s public policy fellows program, Dr. Imperato will have the opportunity to work with AAI on public policy initiatives and meet with policymakers on Capitol Hill.
“I am honored to have been named an AAI Public Policy Fellow,” said Dr. Imperato. “Public support has been a critical element of biomedical discoveries that have positively affected the lives of millions of patients. I look forward to articulating the importance of this support to elected officials and policymakers.”
Dr. Imperato studies under the mentorship of Sangeeta S. Chavan, PhD, and Kevin J. Tracey, MD, and is completing a clinical fellowship with Vincent R. Bonagura, MD, in Northwell Health’s Division of Allergy & Immunology.
“We are very pleased that Dr. Imperato has been selected for this important fellowship, which will further expand his knowledge of medical research and understanding of public policy,” said Annette T. Lee, PhD, dean of the Elmezzi Graduate School of Molecular Medicine. “These are all important building blocks to becoming a leading physician-scientist committed to discovering the causes of human diseases and translating research into diagnostic and therapeutic solutions.”
About the Feinstein Institute
The Feinstein Institute for Medical Research is the research arm of Northwell Health, the largest healthcare provider in New York. Home to 50 research laboratories and to clinical research throughout dozens of hospitals and outpatient facilities, the Feinstein Institute includes 4,000 researchers and staff who are making breakthroughs in molecular medicine, genetics, oncology, brain research, mental health, autoimmunity, and bioelectronic medicine – a new field of science that has the potential to revolutionize medicine. For more information about how we empower imagination and pioneer discovery, visit FeinsteinInstitute.org.
For media inquiries, please contact:
Heather E. Ball Mayer